Disclosure Panels Details Page

Genetic/Familial High-Risk Assessment: Colorectal Panel - Disclosures as of 05/29/2023

Panel Member
(Spouse/Domestic Partner/Dependent)
Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Date Completed
Lisen Axell MS None Natera None None 01/16/2023
Marian Birkeland PhD None None None None 12/12/2022
Nicole Blankenhorn None None None None 03/21/2023
Carol Burke MD Emtora biosciences
Freenome inc
guardant health
sebela
ambry None 04/16/2023
Lee-May Chen MD AstraZeneca Pharmaceuticals LP
Genentech, Inc.
GlaxoSmithKline
None None None 02/05/2023
Daniel Chung MD Immunovia
Iterative Scopes
Janssen Pharmaceutica Products, LP
Guardant None None 02/02/2023
Katherine Clayback MS,CGC None None None None 01/27/2023
Susan Dallas None None None None 05/18/2023
Susan Darlow PhD None None None None 01/04/2023
Mary Dwyer MS None None None None 05/11/2023
Seth Felder MD None None None None 02/22/2023
Francis Giardiello MD,MBA None None Steinberg Gastroenterology Board Review Course None 02/28/2023
William Grady MD Diacarta
Janssen Pharmaceutica Products, LP
Lucid Technologies
Nephron
Tempus
Freenome
Guardant Health
Helio
SEngine
GLG
UpToDate
WebMD
None 02/06/2023
Kristina Gregory MSN,RN,OCN None None None None 03/13/2023
Samir Gupta MD Epigenomics
Freenome
Cellmax
Geneoscopy
Guardant
Intervenn
None Cellmax LLC|Epigenomics|Freenome 03/29/2023
Andrea Hagemann MD,MSCI None None None None 02/15/2023
Michael Hall MS,MD Caris Life Sciences
Invitae
Myriad Genetic Laboratories, Inc.
Eisai Inc.
GRAIL
Natera
None None 11/01/2022
Heather Hampel MS,LGC National Cancer Institute 23andMe
AIM Specialty Health
Genome Medical
GI OnDemand
Natera
None None 02/20/2023
Erin Hesler None None None None 04/04/2023
Rachel Hodan MS,CGC None None None None 04/13/2023
Gregory Idos MS,MD None None None None 04/26/2023
Robin Isaac PharmD None None None None 01/17/2023
Nawal Kassem MD,MS None None None None 10/18/2022
Bryson Katona MD,PhD Ambry
Freenome
GeneDx
Guardant
Immunovia
Invitae
Janssen Pharmaceutica Products, LP
Myriad Genetic Laboratories, Inc.
Universal Diagnostics
None None None 12/13/2022
AnnMarie Kieber-Emmons MD None None Veracyte None 05/22/2023
Laura Lamps MD None Scientific Symposiums International None None 05/24/2023
Xavier Llor PhD,MD None None None None 05/15/2023
Karen Lu MD NA NA NA NA Pending
Arnold Markowitz MD None None None None 09/27/2022
Mariana Niell-Swiller MS None None None None 07/01/2022
Darryl Outlaw MD None None None None 12/14/2022
Sara Pirzadeh-Miller MS,CGC None None None None 01/20/2023
Donna Powell CMD,DHSc,RT(T) None None None None 05/11/2023
Jewel Samadder MD Cancer Insight
Cancer Prevention Pharmaceuticals
Janssen Pharmaceutica Products, LP
Cancer Prevention Pharmaceuticals
Guardant
Janssen Pharmaceutica Products, LP
One Two Therapeutics
Recursion Pharmaceuticals
None None 10/03/2022
David Shibata MD,FACS,FASCRS None None None None 05/26/2023
Peter Stanich MD Emtora Biosciences
Freenome
Gaurdant
Invitae Corp.
Janssen Pharmaceutica Products, LP
Pfizer Inc.
PTEN Research foundation
None UpToDate, Inc. Collaborative Group of the Americas on Inherited Gastrointestinal Cancers 02/14/2023
Benjamin Swanson PhD,MD None Cogen Bioscience The France Foundation, American Society for Clinical Pathology, Association of Community Cancer Centers, Sponsored by an Educational Grant from Pfizer Cogen Bioscience 05/15/2023
Brittany Szymaniak PhD,CGC None "Technology-enhanced AcceleRation of Germline Evaluation for Therapy - The TARGET study" which has been funded by the Prostate Cancer Foundation. Janssen Pharmaceutica Products, LP
UroGPO
None 05/19/2023
Jennifer Weiss MS,MD Exact Sciences None American College of Gastroenterology
American College of Physicians
None 05/01/2023
Jeanna Welborn MD None None None None 02/16/2023
Georgia Wiesner MD None None None None 01/03/2023
Matthew Yurgelun MD Janssen Pharmaceutica Products, LP UpToDate None Facing Our Risk of Cancer Empowered (FORCE) advocacy group 01/28/2023